Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI114429

Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure.

J J Mercadier, A M Lompré, P Duc, K R Boheler, J B Fraysse, C Wisnewsky, P D Allen, M Komajda, and K Schwartz

Institut National de la Santé et de la Recherche Medicale Unité 127, Hôpital Lariboisière, Paris, France.

Find articles by Mercadier, J. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Medicale Unité 127, Hôpital Lariboisière, Paris, France.

Find articles by Lompré, A. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Medicale Unité 127, Hôpital Lariboisière, Paris, France.

Find articles by Duc, P. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Medicale Unité 127, Hôpital Lariboisière, Paris, France.

Find articles by Boheler, K. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Medicale Unité 127, Hôpital Lariboisière, Paris, France.

Find articles by Fraysse, J. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Medicale Unité 127, Hôpital Lariboisière, Paris, France.

Find articles by Wisnewsky, C. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Medicale Unité 127, Hôpital Lariboisière, Paris, France.

Find articles by Allen, P. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Medicale Unité 127, Hôpital Lariboisière, Paris, France.

Find articles by Komajda, M. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Medicale Unité 127, Hôpital Lariboisière, Paris, France.

Find articles by Schwartz, K. in: JCI | PubMed | Google Scholar

Published January 1, 1990 - More info

Published in Volume 85, Issue 1 on January 1, 1990
J Clin Invest. 1990;85(1):305–309. https://doi.org/10.1172/JCI114429.
© 1990 The American Society for Clinical Investigation
Published January 1, 1990 - Version history
View PDF
Abstract

A decrease in the myocardial level of the mRNA encoding the Ca2(+)-ATPase of the sarcoplasmic reticulum (SR) has been recently reported during experimental cardiac hypertrophy and failure. To determine if such a deficit occurs in human end-stage heart failure, we compared the SR Ca2(+)-ATPase mRNA levels in left (LV) and right ventricular (RV) specimens from 13 patients undergoing cardiac transplantation (6 idiopathic dilated cardiomyopathies; 4 coronary artery diseases with myocardial infarctions; 3 diverse etiologies) with control heart samples using a rat cardiac SR Ca2(+)-ATPase cDNA probe. We observed a marked decrease in the mRNA for the Ca2(+)-ATPase relative to both the 18S ribosomal RNA and the myosin heavy chain mRNA in LV specimens of patients with heart failure compared to controls (-48%, P less than 0.01 and -47%, P less than 0.05, respectively). The LV ratio of Ca2(+)-ATPase mRNA to 18S RNA positively correlated with cardiac index (P less than 0.02). The RV ratio correlated negatively with systolic, diastolic and mean pulmonary arterial pressures (P less than 0.02, P less than 0.02, and P less than 0.01, respectively). We suggest that a decrease of the SR Ca2(+)-ATPase mRNA in the myocardium plays an important role in alterations of Ca2+ movements and myocardial relaxation reported during human end-stage heart failure.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 305
page 305
icon of scanned page 306
page 306
icon of scanned page 307
page 307
icon of scanned page 308
page 308
icon of scanned page 309
page 309
Version history
  • Version 1 (January 1, 1990): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts